智能手机电子知情同意在急性卒中试验中的应用
该研究描述了在取栓试验中使用智能手机电子知情同意(e-Consent)工具的经验。在DAWN试验期间,6名代理人通过e-Consent同意,4例患者入组;e-Consent组与传统同意组年龄和NIHSS相似,但入院至随机化时间更短(28±9 vs 57±24分钟,P=0.002)。
要点
- e-Consent工具基于REDCap,符合HIPAA,通过短信或邮件发送链接给合法授权代表。
- e-Consent组入院至随机化时间显著短于传统同意组(28±9 vs 57±24分钟,P=0.002)。
- e-Consent组与传统同意组年龄和NIHSS无显著差异。
核心结论
- 在急性大血管闭塞性卒中随机试验中,e-Consent简化了知情同意流程。
研究设计与样本
- 研究描述了在DAWN随机试验中试点e-Consent工具的应用;该工具为基于REDCap的智能手机平台,符合HIPAA。
- DAWN试验纳入晚就诊患者,比较血管内治疗与药物治疗;2015年1月开始入组,2016年12月e-Consent获IRB批准,2017年2月研究停止。
主要发现
- 试验期间Grady Memorial Hospital共进行273例取栓,47例患者被同意,38例入组DAWN试验。
- 随机化患者中29例(76%)由外院转入。
- 共6名代理人通过e-Consent同意,其中2例患者筛查失败。
- e-Consent入组患者(n=4)与传统同意患者(n=25)年龄(73±14 vs 69±12岁,P=0.65)和NIHSS(16±5 vs 16±5,P=0.88)相似。
- e-Consent组入院至随机化时间缩短(28±9 vs 57±24分钟,P=0.002)。
临床怎么用
- 在急性卒中试验中,可考虑使用智能手机电子知情同意工具以简化同意流程并缩短入院至随机化时间。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: The informed consent process is a major limitation for enrollment in acute stroke clinical investigations. We aim to describe the novel application of smartphone electronic informed consenting (e-Consent) in trials of cerebral thrombectomy. METHODS: The e-Consent tool consists of a secure/Health Insurance Portability and Accountability Act compliant smartphone platform based on REDCap (Research Electronic Data Capture; Vanderbilt University, TN) that uses a survey project located on a static webpage. A link to the webpage is sent via text message or email to the legally authorized representative. The e-Consent form is filled and a freehand electronic signature added in the smartphone browser; a record ID and an e-Consent Process Attestation form are automatically generated. The e-Consent application was piloted in a randomized trial comparing endovascular versus medical therapy in late presenting patients (DAWN [Clinical Mismatch in the Triage of Wake Up and Late Presenting Strokes Undergoing Neurointervention With Trevo]). Trial enrollment began in January 2015; e-Consent was approved by the local institutional review board in December 2016, and the study was stopped in February 2017. RESULTS: During the trial period, Grady Memorial Hospital performed 273 thrombectomies with 47 patients being consented and 38 patients enrolled in the DAWN trial. Of the randomized patients, 29 (76%) were transferred from outside hospitals. A total of 6 surrogates were e-Consented, with 2 patients being screen failures. Enrolled e-Consented patients (n=4) had similar age (73±14 versus 69±12 years; P=0.65) and National Institutes of Health Stroke Scale (16±5 versus 16±5; P=0.88) as compared with conventionally consented (n=25). Time from door-to-randomization was decreased with e-Consenting (28±9 versus 57±24 minutes; P=0.002). CONCLUSIONS: e-Consenting streamlined the consenting process in a randomized trial of patients with emergent large vessel occlusion strokes.
引用
- Haussen DC, Doppelheuer S, Schindler K, et al. Utilization of a Smartphone Platform for Electronic Informed Consent in Acute Stroke Trials. Stroke. 2017. PMID: 28986425. doi:10.1161/STROKEAHA.117.018380
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。